Acute kidney injury: Taking aim at colistin

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Rashid, Shayan ^a   Saro Nunez, Lilian ^a   Kumar, Akanksha ^a   Patel, Amit ^a   Parikh, Amay ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; CREATININE; ANTIINFECTIVE AGENT; COLISTIN;

ACUTE KIDNEY FAILURE; CONTINUOUS RENAL REPLACEMENT THERAPY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; HUMAN; LETTER; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; PATIENT SAFETY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RISK FACTOR; URINE VOLUME; ACUTE KIDNEY INJURY; CRITICAL ILLNESS; DRUG EFFECTS; FEMALE; KIDNEY; MALE;

ACUTE KIDNEY INJURY; ANTI-BACTERIAL AGENTS; COLISTIN; CRITICAL ILLNESS; FEMALE; HUMANS; KIDNEY; MALE;

EID: 84892665017     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13703     Document Type: Letter

References (3)

1. Rocco M, Montini L, Alessandri E, Venditti M, Laderchi A, De Pascale G, Raponi G, Vitale M, Pietropaoli P, Antonelli M. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study. Crit Care 2013, 17:R174. 10.1186/cc12853, 23945197.
2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212. 10.1186/cc2872, 522841, 15312219.
3. Karnik ND, Sridharan K, Jadhav SP, Kadam PP, Naidu RK, Namjoshi RD, Gupta V, Gore MS, Surase PV, Mehta PR, Gogtay JA, Thatte UM, Gogtay NJ. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection. Eur J Clin Pharmacol 2013, 69:1429-1436. 10.1007/s00228-013-1493-9, 23508665.